Alpha-1 antitrypsin - Omni Bio Pharmaceutical

Drug Profile

Alpha-1 antitrypsin - Omni Bio Pharmaceutical

Alternative Names: p-AAT; Plasma-derived alpha 1 antitrypsin - Omni Bio Pharmaceutical

Latest Information Update: 07 Apr 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator University of Colorado at Denver
  • Developer Colorado State University; Omni Bio Pharmaceutical; University of Colorado at Denver; Virginia Commonwealth University
  • Class Acute-phase proteins; Alpha globulins; Blood proteins; Secretory proteinase inhibitory proteins; Serpins
  • Mechanism of Action Pancreatic elastase inhibitors; Trypsin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Discontinued Anthrax; Graft-versus-host disease; HIV infections; Influenza virus infections; Myocardial infarction; Pneumonia; Tuberculosis; Type 1 diabetes mellitus; Type 2 diabetes mellitus

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 09 Dec 2014 Interim efficacy, adverse events and pharmacodynamics data from a phase I/II trial in Graft-versus-host disease presented at the 56th Annual Meeting and Exposition of the American Society of Hematology (ASH-2014)
  • 30 Apr 2014 Final efficacy, adverse events and pharmacodynamics data from a clinical trial in Type 1 diabetes mellitus released by Omni Bio Pharmaceutical
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top